Disease progression of cancer patients during COVID-19 pandemic: a comprehensive analytical strategy by time-dependent modelling.

Atanu BhattacharjeeGajendra K VishwakarmaSouvik BanerjeeSharvari Shukla

Published in: BMC medical research methodology (2020)

We provide the solutions to overcome the issue with intervals between two consecutive events in motivating head and neck cancer (HNC) data. COVID-19 is not going to leave us soon. We have to conduct several cancer clinical trials in the presence of COVID-19. A comprehensive analytical strategy to analyse cancer clinical trial data during COVID-19 pandemic is presented.

Keyphrases

clinical trial
coronavirus disease
papillary thyroid
sars cov
squamous cell
electronic health record
big data
phase ii
open label
randomized controlled trial
lymph node metastasis
data analysis
respiratory syndrome coronavirus
liquid chromatography